Table 2 Differentially expressed cord blood genes in bronchopulmonary dysplasia (BPD).
Functions and Pathways | Gene | p | FC | Description |
|---|---|---|---|---|
Immunity | BCL2 | 2.80E−03 | − 1.90 | BCL2 apoptosis regulator |
CCR7 | 1.68E−02 | − 1.83 | C–C motif chemokine receptor 7 | |
CD247 | 3.43E−02 | − 1.54 | CD247 molecule | |
CD27 | 5.80E−03 | − 1.93 | CD27 molecule | |
CD28 | 2.73E−02 | − 1.63 | CD28 molecule | |
CD79B | 1.80E−02 | − 1.95 | CD79b molecule | |
HLA-DQA2† | 1.82E−02 | − 3.03 | Major histocompatibility complex, class II, DQ alpha 2 | |
ICOS | 9.42E−03 | − 1.81 | Inducible T cell costimulator | |
IGLV2-14 | 1.24E−02 | − 2.25 | Immunoglobulin lambda variable 2–14 | |
IL18R1* | 3.61E−05 | − 3.35 | Interleukin 18 receptor 1 | |
IL18RAP† | 4.08E−03 | − 1.97 | Interleukin 18 receptor accessory protein | |
IL21R | 1.80E−02 | − 2.34 | Interleukin 1 receptor type 2 | |
LCK† | 7.30E−03 | − 1.83 | LCK proto-oncogene, Src family tyrosine kinase | |
PGLYRP2 | 2.31E−02 | 8.32 | Peptidoglycan recognition protein 2 | |
RAG2 | 1.56E−02 | 8.96 | Recombination activating 2 | |
STAT4 | 5.13E−03 | − 1.88 | Signal transducer and activator of transcription 4 | |
TRBJ1-1 | 1.52E−02 | − 4.72 | T cell receptor beta joining 1–1 | |
TRAV16 | 7.99E−03 | − 3.93 | T cell receptor alpha variable 16 | |
ZAP70 | 1.05E−02 | − 1.93 | Zeta chain of T cell receptor associated protein kinase 70 | |
Immune-mediated inflammation, leukocyte migration, interferon signaling | CD83 | 7.56E−03 | 1.88 | CD83 molecule |
CXCL8 | 4.02E−02 | 3.96 | C–X–C motif chemokine ligand 8 | |
GBP3 | 6.74E−03 | − 1.93 | Guanylate binding protein 3 | |
IFITM3† | 1.91E−02 | − 1.90 | Interferon induced transmembrane protein 3 | |
ITGA6 | 3.32E−02 | − 1.64 | Integrin subunit alpha 6 | |
MAPK9 | 3.59E−02 | 1.43 | Mitogen-activated protein kinase 9 | |
SELP† | 3.22E−02 | − 2.21 | Selectin P | |
SOCS1 | 1.23E−02 | − 2.22 | Suppressor of cytokine signaling 1 | |
TLR4 | 1.13E−02 | − 1.89 | Toll like receptor 4 | |
TNFSF8 | 6.95E−04 | − 2.14 | TNF superfamily member 8 | |
Mitosis, chromosome segregation, DNA repair | AURKB | 1.88E−02 | 1.85 | Aurora kinase B |
BORA* | 3.71E−06 | 1.96 | BORA aurora kinase A activator | |
CDCA8 | 3.11E−04 | 2.21 | Cell division cycle associated 8 | |
MKI67 | 1.06E−02 | 1.62 | Marker of proliferation Ki-67 | |
RAD51* | 2.06E−05 | 3.00 | RAD51 recombinase | |
SPC25† | 1.43E−02 | 2.76 | SPC25 component of NDC80 kinetochore complex | |
TOP3A | 5.76E−03 | 1.47 | DNA topoisomerase III alpha | |
WEE1† | 2.86E−02 | 1.41 | WEE1 G2 checkpoint kinase | |
Cell death, pyroptosis | CASP9 | 5.82E−03 | 1.53 | Caspase 9 |
GSDMD | 4.73E−02 | − 1.49 | Gasdermin D | |
GZMA† | 2.20E−03 | − 1.87 | Granzyme A | |
Respiratory disorders | AGER† | 2.55E−02 | 1.54 | Advanced glycosylation end-product specific receptor |
CAMP | 7.17E−04 | 3.33 | Cathelicidin antimicrobial peptide | |
HBG1* | 1.43E−05 | − 47.85 | Hemoglobin subunit gamma 1 | |
Growth, angiogenesis | ANGPT2† | 2.89E−02 | 5.46 | Angiopoietin 2 |
B4GALT5* | 4.15E−06 | 1.92 | Beta-1,4-galactosyltransferase 5 | |
GPS2 | 9.24E−03 | − 1.88 | G protein pathway suppressor 2 | |
MMUT* | 2.00E−05 | 1.67 | Methylmalonyl-CoA mutase | |
PAPPA2* | 5.09E−38 | > 1000 | Pappalysin 2 | |
PGF† | 1.96E−02 | 5.60 | Placental growth factor | |
SPOCK2† | 2.58E−02 | − 1.91 | SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2 | |
VEGFA | 4.71E−03 | 2.01 | Vascular endothelial growth factor A |